Boyle Scott N has filed 22 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 7269 shares of C4 Therapeutics, Inc. ($CCCC) on February 14, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2026 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | F | Common Stock | 7269 | $1.89 | 298,801.0000 | 96,914,418 | 2.37% | 0.01% |
| Feb. 14, 2026 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | M | Common Stock | 20950 | $0.00 | 306,070.0000 | 96,914,418 | 7.35% | 0.02% |
| Feb. 13, 2026 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | F | Common Stock | 1735 | $1.89 | 306,070.0000 | 96,914,418 | 0.56% | 0.00% |
| Feb. 13, 2026 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | M | Common Stock | 5000 | $0.00 | 307,805.0000 | 96,914,418 | 1.65% | 0.01% |
| Feb. 13, 2026 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | A | Common Stock | 200000 | $0.00 | 307,805.0000 | 96,914,418 | 185.52% | 0.21% |
| Feb. 14, 2025 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | A | Stock Option (Right to Buy) | 84700 | $0.00 | 84,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | F | Common Stock | 1735 | $3.20 | 54,832.0000 | 0 | 3.07% | 0.00% |
| Feb. 14, 2025 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | A | Common Stock | 56500 | $0.00 | 111,332.0000 | 0 | 103.04% | 0.00% |
| Feb. 14, 2025 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | S | Common Stock | 490 | $3.15 | 110,842.0000 | 0 | 0.44% | 0.00% |
| Feb. 14, 2025 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | F | Common Stock | 2368 | $3.18 | 108,474.0000 | 0 | 2.14% | 0.00% |
| Feb. 18, 2025 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | S | Common Stock | 669 | $3.15 | 107,805.0000 | 0 | 0.62% | 0.00% |
| Nov. 7, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | M | Performance Restricted Stock Units | 3750 | $0.00 | 10,500.0000 | 0 | 26.32% | 0.00% |
| Nov. 7, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | M | Common Stock | 3750 | $0.00 | 57,669.0000 | 0 | 6.95% | 0.00% |
| Nov. 7, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | F | Common Stock | 1102 | $6.04 | 56,567.0000 | 0 | 1.91% | 0.00% |
| Sept. 16, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | M | Performance Restricted Stock Units | 2250 | $0.00 | 14,250.0000 | 0 | 13.64% | 0.00% |
| Sept. 16, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | F | Common Stock | 661 | $6.36 | 53,919.0000 | 0 | 1.21% | 0.00% |
| Sept. 16, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | M | Common Stock | 2250 | $0.00 | 54,580.0000 | 0 | 4.30% | 0.00% |
| March 7, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | D | Stock Option (Right to Buy) | 115000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | F | Common Stock | 1735 | $6.53 | 25,030.0000 | 0 | 6.48% | 0.00% |
| Feb. 14, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | A | Common Stock | 27300 | $0.00 | 52,330.0000 | 0 | 109.07% | 0.00% |
| Feb. 14, 2024 | C4 Therapeutics, Inc. | $CCCC | Boyle Scott N | Chief Business Officer | A | Stock Option (Right to Buy) | 122800 | $0.00 | 122,800.0000 | 0 | 9999.99% | 0.00% |